Prevalence, management, and new treatment modalities of EBV-DNA-emia and EBV-PTLD after allo-HCT: survey of Infectious Diseases Working Party EBMT
Bone Marrow Transplantation, Published online: 23 October 2023; doi:10.1038/s41409-023-02129-7Prevalence, management, and new treatment modalities of EBV-DNA-emia and EBV-PTLD after allo-HCT: survey of Infectious Diseases Working Party EBMT (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - October 23, 2023 Category: Hematology Authors: Jan Styczynski Gloria Tridello Lotus Wendel Nina Knelange Simone Cesaro Lidia Gil Per Ljungman Malgorzata Mikulska Dina Averbuch Rafael de la Camara Source Type: research
Outcomes for patients with EBV-positive PTLD post-allogeneic HCT after failure of rituximab-containing therapy
Bone Marrow Transplantation, Published online: 21 October 2023; doi:10.1038/s41409-023-02127-9Outcomes for patients with EBV-positive PTLD post-allogeneic HCT after failure of rituximab-containing therapy (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - October 21, 2023 Category: Hematology Authors: G érard Socié Pere Barba Arie Barlev Jaime Sanz Irene Garc ía-Cadenas Patrice Chevallier Franca Fagioli Norma Guzman-Becerra Deepali Kumar Per Ljungman Arnaud Pigneux Natalia Sadetsky Lucrecia Y áñez San Segundo Mazyar Shadman Jan Storek Dhanalakshmi Source Type: research
Vampires, blood and wine
Bone Marrow Transplantation, Published online: 20 October 2023; doi:10.1038/s41409-023-02132-yVampires, blood and wine (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - October 20, 2023 Category: Hematology Authors: Shaun McCann Source Type: research
Reducing the risks of nuclear war—the role of health professionals
Bone Marrow Transplantation, Published online: 20 October 2023; doi:10.1038/s41409-023-02126-wReducing the risks of nuclear war—the role of health professionals (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - October 20, 2023 Category: Hematology Authors: Kamran Abbasi Parveen Ali Virginia Barbour Kirsten Bibbins-Domingo Marcel GM Olde Rikkert Richard Horton Robert Mash Carlos Monteiro Elena N. Naumova Eric J. Rubin Peush Sahni James Tumwine Paul Yonga Chris Zielinski Arun Mitra Tilman Ruff Andy Haines Ira Source Type: research
CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation
Bone Marrow Transplantation, Published online: 19 October 2023; doi:10.1038/s41409-023-02124-yCMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - October 19, 2023 Category: Hematology Authors: Michele Malagola Vera Radici Mirko Farina Simone Pellizzeri Filippo Spoldi Enrico Morello Nicola Polverelli Eugenia Accorsi Buttini Simona Bernardi Federica Re Alessandro Leoni Liana Signorini Arnaldo Caruso Domenico Russo Source Type: research
Allogeneic stem cell transplant for treatment of mycosis fungoides and Sezary syndrome: a systematic review and meta-analysis
Bone Marrow Transplantation, Published online: 18 October 2023; doi:10.1038/s41409-023-02122-0Allogeneic stem cell transplant for treatment of mycosis fungoides and Sezary syndrome: a systematic review and meta-analysis (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - October 18, 2023 Category: Hematology Authors: Amrita Goyal Daniel O ’Leary Francine Foss Source Type: research
Predictors of outcomes in hematopoietic cell transplantation for Fanconi anemia
Bone Marrow Transplantation, Published online: 17 October 2023; doi:10.1038/s41409-023-02121-1Predictors of outcomes in hematopoietic cell transplantation for Fanconi anemia (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - October 17, 2023 Category: Hematology Authors: Maria Cancio Alexandre G. Troullioud Lucas Marc Bierings Elizabeth Klein Moniek A. de Witte Frans J. Smiers Dorine Bresters Jaap Jan Boelens Stephanie E. Smetsers Source Type: research
Favorable outcomes following CD34-selected stem cell boost for poor graft function after allogeneic hematopoietic stem cell transplantation
Bone Marrow Transplantation, Published online: 13 October 2023; doi:10.1038/s41409-023-02125-xFavorable outcomes following CD34-selected stem cell boost for poor graft function after allogeneic hematopoietic stem cell transplantation (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - October 13, 2023 Category: Hematology Authors: Joe S. Al-Ramahi Moazzam Shahzad Andrea Nguyen Kevin Li Muhammad Kashif Amin Nausheen Ahmed Forat Lutfi Shaun DeJarnette Sibgha Gull Chaudhary Rajat Bansal Haitham Abdelhakim Leyla Shune Al-Ola Abdallah Anurag K. Singh Sunil H. Abhyankar Joseph P. McGuirk Source Type: research
CALR mutations possess unique prognostic relevance in myelofibrosis—before and after transplant
Bone Marrow Transplantation, Published online: 11 October 2023; doi:10.1038/s41409-023-02112-2CALR mutations possess unique prognostic relevance in myelofibrosis—before and after transplant (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - October 11, 2023 Category: Hematology Authors: Ayalew Tefferi Alessandro M. Vannucchi Source Type: research
Low incidence of engraftment syndrome following allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide
Bone Marrow Transplantation, Published online: 11 October 2023; doi:10.1038/s41409-023-02123-zLow incidence of engraftment syndrome following allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - October 11, 2023 Category: Hematology Authors: Daniel J. Ikeda Zachariah DeFilipp Kerry Collier Yi-Bin Chen Bimalangshu R. Dey Areej El-Jawahri Matthew J. Frigault Mark B. Leick Steven L. McAfee Richard A. Newcomb Paul V. O ’Donnell Thomas R. Spitzer Source Type: research
Transplant conditioning with bortezomib, thalidomide, and melphalan and intensive 2 year post-transplant therapy for multiple myeloma in older patients
Bone Marrow Transplantation, Published online: 10 October 2023; doi:10.1038/s41409-023-02119-9Transplant conditioning with bortezomib, thalidomide, and melphalan and intensive 2 year post-transplant therapy for multiple myeloma in older patients (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - October 10, 2023 Category: Hematology Authors: Christopher Strouse Sarah L. Mott Brian J. Smith Margarida Magalhaes-Silverman Umar Farooq Fenghuang Zhan Yogesh Jethava Guido Tricot Source Type: research
Comparison of MEAM, MCEC and LEED high-dose chemotherapy followed by autologous stem cell transplantation in relapsed/refractory diffuse large B-cell lymphoma: data from the Japan Society for Hematopoietic and Cellular Therapy Registry
Bone Marrow Transplantation, Published online: 07 October 2023; doi:10.1038/s41409-023-02118-wComparison of MEAM, MCEC and LEED high-dose chemotherapy followed by autologous stem cell transplantation in relapsed/refractory diffuse large B-cell lymphoma: data from the Japan Society for Hematopoietic and Cellular Therapy Registry (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - October 7, 2023 Category: Hematology Authors: Risa Koresawa-Shimizu Ritsuro Suzuki Yasufumi Uehara Nobuhiro Hiramoto Masashi Sawa Takahiro Fukuda Keisuke Kataoka Yoshinobu Kanda Tatsuo Oyake Yasushi Kubota Naoyuki Uchida Shingo Yano Hikaru Kobayashi Junji Tanaka Yoshiko Atsuta Eisei Kondo Source Type: research
Blood and marrow transplant within 4 weeks of SARS-CoV-2 infection is associated with increased risk of mortality: a National COVID Cohort Collaborative (N3C) Study
Bone Marrow Transplantation, Published online: 06 October 2023; doi:10.1038/s41409-023-02096-zBlood and marrow transplant within 4 weeks of SARS-CoV-2 infection is associated with increased risk of mortality: a National COVID Cohort Collaborative (N3C) Study (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - October 6, 2023 Category: Hematology Authors: Meera Mohan Anai Kothari Nathaniel Verhagen Aditya Shreenivas Sabarinath Venniyil Radhakrishnan Binod Dhakal Carlos Figueroa-Castro Saurabh Chhabra Siegfried Janz Marcello Pasquini Mehdi Hamadani Aniko Szabo Anita D ’Souza Source Type: research
Autoimmune cytopenias following pediatric hematopoietic cell transplant
Bone Marrow Transplantation, Published online: 04 October 2023; doi:10.1038/s41409-023-02116-yAutoimmune cytopenias following pediatric hematopoietic cell transplant (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - October 4, 2023 Category: Hematology Authors: Jacob R. Greenmyer Sydney Ariagno Asma Ali Lindy Pence Mary O ’Shea Lauren A. Greenmyer Shakila Khan Alexis Kuhn Catherine Martin Asmaa Ferdjallah Mira Kohorst Source Type: research
Current use of fecal microbiota transfer in patients with hematologic diseases: a survey on behalf of the Cellular Therapy and Immunobiology Working Party of the EBMT
Bone Marrow Transplantation, Published online: 03 October 2023; doi:10.1038/s41409-023-02115-zCurrent use of fecal microbiota transfer in patients with hematologic diseases: a survey on behalf of the Cellular Therapy and Immunobiology Working Party of the EBMT (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - October 3, 2023 Category: Hematology Authors: Giorgia Battipaglia Jarl E. Mooyaart Ralf Meyer Mohamad Mohty Alicja Sadowska-Klasa Oleg Goloshchapov Franco Locatelli Jan Styczynski Jiri Pavlu Jaroslaw Dybko Gleb Bronin Urpu Salmenniemi Pavel Jindra Jorinde D. Hoogenboom Jurgen Kuball Annalisa Ruggeri Source Type: research